The latest price target for Biotricity (OTCQB:BTCY) was reported by HC Wainwright & Co. on November 18, 2024. The analyst firm set a price target for $0.00 expecting BTCY to fall to within 12 months (a possible -100.00% downside). 1 analyst firms have reported ratings in the last year.

The latest analyst rating for Biotricity (OTCQB:BTCY) was provided by HC Wainwright & Co., and Biotricity reiterated their neutral rating.

There is no last upgrade for Biotricity

The last downgrade for Biotricity Inc happened on November 20, 2023 when HC Wainwright & Co. changed their price target from N/A to N/A for Biotricity Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Biotricity, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Biotricity was filed on November 18, 2024 so you should expect the next rating to be made available sometime around November 18, 2025.

While ratings are subjective and will change, the latest Biotricity (BTCY) rating was a reiterated with a price target of $0.00 to $0.00. The current price Biotricity (BTCY) is trading at is $0.32, which is out of the analyst’s predicted range.